Recommendations made by the PBAC – December 2021 intracycle meeting

28 January 2022 - Recommendations made by the PBAC in December 2021 relating to the listing of drugs on the PBS ...

Read more →

'I feel like I'm drowning': thousands with cystic fibrosis wait to hear if 'life-saving' drug will be listed on PBS

27 January 2022 - Matt Dickinson was struggling to breathe when his mother rushed him to an Adelaide hospital earlier ...

Read more →

Australians deserve fast access to the latest medicines, vaccines and treatments

28 January 2022 - Medicines Australia recommends the Australian Government delivers a plan to shorten the time that patients wait ...

Read more →

Pfizer's COVID-19 vaccine (Comirnaty) provisionally approved for use as a booster in individuals aged 16-17 years old

28 January 2022 - The Therapeutic Goods Administration has provisionally approved the Pfizer COVID-19 vaccine, Comirnaty for use as a ...

Read more →

Moderna aims to deliver Omicron COVID-19 vaccine by September

27 January 2022 - A COVID-19 booster shot, targeted specifically at the Omicron variant, is expected to be delivered by ...

Read more →

TGA approves Tepmetko for patients with non-small-cell lung cancer

27 January 2022 - Tepotinib (Tepmetko) has provisional approval in Australia for the treatment of adult patients with locally advanced or ...

Read more →

COVID-19 vaccine weekly safety report (27 January 2022)

27 January 2022 - To 23 January 2022, the TGA has received 431 reports which have been assessed as likely to ...

Read more →

2022 April price disclosure cycle – indicative prices

27 January 2022 - Indicative 1 April 2022 prices resulting from the 2022 April Cycle of Price Disclosure have now been ...

Read more →

TGA approves MSD's Vaxneuvance

24 January 2022 - Vaxneuvance (pneumococcal 15 valent conjugate vaccine (CRM197 protein)) was approved on 17 January 2022 for active ...

Read more →

Novavax COVID-19 vaccine to be available in coming weeks

24 January 2022 - Australians aged 18+ will now have access to a fourth COVID-19 vaccine, Nuvaxovid (Novavax) in coming weeks, ...

Read more →

Australians with severe dermatitis to benefit from PBS listing

24 January 2022 - From 1 February 2022, Australians with severe atopic dermatitis will have access to a new treatment ...

Read more →

ATAGI statement on the use of Novavax COVID-19 vaccine (Nuvaxovid)

24 January 2022 - ATAGI recommends that Novavax COVID-19 vaccine can be used for the primary course of COVID-19 vaccination ...

Read more →

Pharmacists struggle to meet demand for free COVID test kits amid stock shortage

23 January 2022 - Chemists across the country say they do not have enough rapid antigen tests to start handing ...

Read more →

Thousands to benefit from decision to subsidise eczema treatment

23 January 2022 - Australians suffering from a severe form of eczema will save tens of thousands of dollars after a ...

Read more →

National Medicines Policy Review – publication of submissions

21 January 2022 - On 30 August 2021, the National Medicines Policy Review Committee invited submissions to support the Review of ...

Read more →